PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Applied Health Research, University of Birmingham, Birmingham, UK, and Warwick Medical School, University of Warwick, Coventry, UK.\', \'Institute of Applied Health Research, University of Birmingham, Birmingham, UK.\', \'Cegedim Rx, London, UK.\', \'Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.\', \'Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Institute of Inflammation and Ageing, University of Birmingham, MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, UK.\', \'Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK, and Institute of Inflammation and Ageing, MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, UK.\', \'Institute of Inflammation and Ageing, MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, Sandwell and West Birmingham NHS Hospitals Trust, Birmingham, UK.\', \'Institute of Applied Health Research, University of Birmingham, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Institute of Applied Health Research, University of Birmingham, Health Data Research UK Midlands, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/art.41593
?:hasPublicationType
?:journal
  • Arthritis & rheumatology (Hoboken, N.J.)
is ?:pmid of
?:pmid
?:pmid
  • 33185016
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all